| |
Norwalk, CT (November 1, 2002) -- The Auto Suture Division
of United States Surgical, a division of Tyco Healthcare Group
LP, announced today that it will now offer surgical access
port products featuring VersaSeal* Plus technology, a state-of-the-art
seal system providing surgeons with a broad range of benefits.
VersaSeal* Plus will be offered on select products in the
VersaPort*, VersaPort RT*, Visiport*, Bluntport*, and VersaStep*
lines.
"The Auto Suture Division of United States Surgical is
focused on providing surgeons and health care professionals
with innovative solutions to their needs," said Ronald
F. Galovich, vice president, marketing of United States Surgical.
"With this in mind, VersaSeal* Plus is a completely new
and revolutionary technology that will be a key element in
the high performance and success of our access port products
as we move forward."
A universal seal that self-adjusts to accept 4.5mm-12mm instruments
without external converters, VersaSeal* Plus provides hands
free exchange of instruments and has been shown to be extremely
durable. The design of VersaSeal* Plus minimizes the potential
for tears or leakage during instrument insertion or manipulation,
and offers surgeons improved tactile feel and more precise
movement.
VersaSeal* Plus will be available immediately. United States
Surgical is working closely with customers to ensure that
they experience virtually no inconvenience as a result of
the transition to the new VersaSeal* Plus technology.
About United States Surgical
United States Surgical, a division of Tyco Healthcare Group
LP, is a diversified medical products company specializing
in minimally invasive technologies that improve patient care
and offer the best efficiencies for healthcare providers.
About Tyco Healthcare
Tyco Healthcare is one of the major business units of Tyco
International (NYSE: TYC, LSE: TYI, BSX: TYC). Tyco Healthcare
is a leading manufacturer, distributor and servicer of medical
devices worldwide. Its broad portfolio includes disposable
medical supplies, monitoring equipment, medical instruments
and bulk analgesic pharmaceuticals, sold under such names
as Auto Suture, Graphic Controls, Kendall, Mallinckrodt, Nellcor,
Puritan Bennett, Sherwood, United States Surgical, Valleylab
and others.
Forward-Looking Information
This release contains certain "forward-looking statements"
within the meaning of the United States Private Securities
Litigation Reform Act of 1995. These statements are based
on management's current expectations and are subject to risks,
uncertainty and changes in circumstances, which may cause
actual results, performance or achievements to differ materially
from anticipated results, performance or achievements. All
statements contained herein that are not clearly historical
in nature are forward looking and the words "anticipate,"
"believe," "expect," "estimate,"
"plan," and similar expressions are generally intended
to identify forward-looking statements.
The forward-looking statements in this release include statements
addressing
future financial condition and operating results. Economic,
business, competitive and/or regulatory factors affecting
Tyco's businesses are examples of factors, among others, that
could cause actual results to differ materially from those
described in the forward-lookingstatements. Tyco is under
no obligation to (and expressly disclaims any such
obligation to) update or alter its forward-looking statements
whether as a result of new information, future events or otherwise.
For Further Information About VersaSeal* Plus,
Please contact United States Surgical Customer Service Department:
Phone: 1 800 722 8772;
Fax: 1 800 544 8772.
Contacts:
Peter Ferris
Tyco International Ltd.
(212) 424-1366
Steve Lampkin,
US Surgical
(203) 845-1464
|
